DT&CRO (KOSDAQ:A383930) - Stock Price, News & Analysis

A383930 Stock Overview

Operates as a full-service CRO provider in South Korea. More details

A383930 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Volatile share price over the past 3 months compared to the KR market

Does not have a meaningful market cap (₩73B)

DT&CRO CO., Ltd. Competitors

DreamCIS

KOSDAQ:A223250

₩74.7b

Hyundai ADM Bio

KOSDAQ:A187660

₩69.8b

C&R Research

KOSDAQ:A359090

₩65.8b

P&K Skin Research Center

KOSDAQ:A347740

₩62.8b

Price History & Performance

Summary of all time highs, changes and price drops for DT&CRO
Historical stock prices
Current Share Price	₩5,700.00
52 Week High	₩24,400.00
52 Week Low	₩5,540.00
Beta	0
11 Month Change	-24.70%
3 Month Change	-17.03%
1 Year Change	-32.78%
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-17.69%

Recent updates

Shareholder Returns

	A383930	KR Life Sciences	KR Market
7D	-6.4%	0.5%	0.9%
1Y	-32.8%	33.0%	-3.4%

Return vs Industry: A383930 underperformed the KR Life Sciences industry which returned 33% over the past year.

Return vs Market: A383930 underperformed the KR Market which returned -3.4% over the past year.

Price Volatility

Is A383930's price volatile compared to industry and market?
A383930 volatility
A383930 Average Weekly Movement	8.5%
Life Sciences Industry Average Movement	8.7%
Market Average Movement	5.7%
10% most volatile stocks in KR Market	11.6%
10% least volatile stocks in KR Market	2.7%

Stable Share Price: A383930's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A383930's weekly volatility has decreased from 16% to 8% over the past year, but is still higher than 75% of KR stocks.

About the Company

Founded	Employees	CEO	Website
2017	n/a	n/a	www.dtncro.com/ko

DT&CRO CO., Ltd. operates as a full-service CRO provider in South Korea. It conducts a series of consigned studies ranging from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics, and medical devices to analysis, bioactivity, clinical trials, and licensing consulting. DT&CRO CO., Ltd.

DT&CRO CO., Ltd. Fundamentals Summary

How do DT&CRO's earnings and revenue compare to its market cap?
A383930 fundamental statistics
Market cap	₩72.56b
Earnings (TTM)	₩0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is A383930 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A383930 income statement (TTM)
Revenue	₩0
Cost of Revenue	₩0
Gross Profit	₩0
Other Expenses	₩0
Earnings	₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did A383930 perform over the long term?

See historical performance and comparison

DT&CRO KOSDAQ:A383930 Stock Report